CUX1/Wnt	NN
signaling	NN
regulates	VBZ
epithelial	JJ
mesenchymal	JJ
transition	NN
in	IN
EBV	NN
infected	JJ
epithelial	JJ
cells	NNS
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
refractory	JJ
and	CC
lethal	JJ
interstitial	JJ
lung	NN
disease	NN
characterized	VBN
by	IN
alveolar	JJ
epithelial	JJ
cells	NNS
apoptosis	NN
,	,
fibroblast	NN
proliferation	NN
and	CC
extra-cellular	JJ
matrix	NN
protein	NN
deposition	NN
.	.

EBV	NN
,	,
localised	JJ
to	TO
alveolar	JJ
epithelial	JJ
cells	NNS
of	IN
pulmonary	JJ
fibrosis	NN
patients	NNS
is	VBZ
associated	VBN
with	IN
a	DT
poor	JJ
prognosis	NN
.	.

A	DT
strategy	NN
based	VBN
on	IN
microarray-differential	JJ
gene	NN
expression	NN
analysis	NN
to	TO
identify	VB
molecular	JJ
drivers	NNS
of	IN
EBV-associated	JJ
lung	NN
fibrosis	NN
was	VBD
utilized	VBN
.	.

Alveolar	JJ
epithelial	JJ
cells	NNS
were	VBD
infected	VBN
with	IN
EBV	NN
to	TO
identify	VB
genes	NNS
whose	WP$
expression	NN
was	VBD
altered	VBN
following	VBG
TGFbeta1-mediated	JJ
lytic	JJ
phase	NN
.	.

EBV	NN
lytic	JJ
reactivation	NN
by	IN
TGFbeta1	NN
drives	VBZ
a	DT
selective	JJ
alteration	NN
in	IN
CUX1	NN
variant	NN
(	(
a	DT
)	)
(	(
NCBI	NN
accession	NN
number	NN
NM	181552	NN
)	)
expression	NN
,	,
inducing	VBG
activation	NN
of	IN
non-canonical	JJ
Wnt	NN
pathway	NN
mediators	NNS
,	,
implicating	VBG
it	PRP
in	IN
Epithelial	JJ
Mesenchymal	JJ
Transition	NN
(	(
EMT	NN
)	)
,	,
the	DT
molecular	JJ
event	NN
underpinning	NN
scar	NN
production	NN
in	IN
tissue	NN
fibrosis	NN
.	.

The	DT
role	NN
of	IN
EBV	NN
in	IN
EMT	NNP
can	MD
be	VB
attenuated	VBN
by	IN
antiviral	JJ
strategies	NNS
and	CC
inhibition	NN
of	IN
Wnt	NN
signaling	NN
by	IN
using	VBG
All-Trans	NNP
Retinoic	JJ
Acids	NNS
(	(
ATRA	NN
)	)
.	.

Activation	NN
of	IN
non-canonical	JJ
Wnt	NN
signaling	NN
pathway	NN
by	IN
EBV	NN
in	IN
epithelial	JJ
cells	NNS
suggests	VBZ
a	DT
novel	JJ
mechanism	NN
of	IN
EMT	NNP
via	IN
CUX1	NN
signaling	NN
.	.

These	DT
data	NNS
present	VBP
a	DT
framework	NN
for	IN
further	JJ
description	NN
of	IN
the	DT
link	NN
between	IN
infectious	JJ
agents	NNS
and	CC
fibrosis	NN
,	,
a	DT
significant	JJ
disease	NN
burden	NN
.	.

